Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / October / LDTs The Hidden Engines of Precision Medicine / Notecards
Technology and innovation Insights Molecular Pathology

LDTs: The Hidden Engines of Precision Medicine

How LDTs give labs the agility to innovate beyond red tape – and deliver critical answers when patients need them most

By Jamie Platt 10/14/2025 Discussion 4 min read
article Full Article Summary Notecard

Share

  1. LDTs help address unmet diagnostic needs for rare diseases.

  2. Regulatory changes now allow laboratories to operate under CLIA for LDTs.

  3. LDTs provide faster diagnosis capabilities than traditional IVDs.

  4. Developing LDTs can significantly reduce costs.

  5. Strategic partnerships enhance resource access for labs.

  6. Labs need to focus on quality and patient outcomes in test development.

  7. Advanced technology democratizes access to sophisticated testing.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Jamie Platt

Jamie Platt is CEO of Pictor, Inc

More Articles by Jamie Platt

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.